The negative regulation of EGFL8 in metastasis of liver cancer cells was further validated by an HCC metastasis mouse model, which showed that the pulmonary metastatic ratio in the EGFL8 overexpression group was significantly lower than the controlled group, indicating EGFL8 as an important modulator in the metastasis of HCC. This evidence concerns the gene EGFL8 and liver cancer.